Prediabetes and CV Risk: Evidence Review in 2025 Dr.Soumya S L11 April 2025 12:30 PM ISTPrediabetes: Potential Cardiovascular (CV) Warning Sign: India has a high prediabetes prevalence (15.3%), nearly equal in urban (15.4%) and rural...
BRESER Study Demonstrates Real-World Efficacy and Safety of Lupin's Ranibizumab Biosimilar (Ranieyes) Deeksha Bhandari11 April 2025 11:24 AM ISTRanieyes is the Ranibizumab Biosimilar which is an Indian Ranibizumab Biosimilar manufactured by Lupin Ltd & approved in India for various...
Darbepoetin alfa (Cresp) for Chemotherapy-induced Anemia: Study Highlights with Dr MV Chandrakanth Deeksha Bhandari10 April 2025 12:30 PM ISTAnemia remains a pervasive yet often underappreciated complication among cancer patients undergoing chemotherapy, significantly impacting their...
Right Turn Show- Exploring Dapagliflozin Beyond Glycemic Benefits Deeksha Bhandari8 April 2025 12:34 PM ISTIn the last episode, we explored the role of Dapagliflozin in specialty care settings. Moving forward, this episode delves into Dapagliflozin Beyond...
Dapagliflozin Sitagliptin-Preferred SGLT2i-DPP4i FDC in Indian Clinical Practice Dr. Saptarshi Bhattacharya7 April 2025 11:34 AM ISTType 2 diabetes mellitus (T2DM) is a major public health challenge in India, with an estimated 101 million individuals affected and 39.4 million...
Indian CV Risk Factors and Emerging Evidence for Aspirin in Primary Prevention- What's New? Dr. Jay Shah5 April 2025 11:32 AM ISTCardiovascular diseases (CVDs) remain the leading cause of mortality and disability in India, contributing to 31.8% of deaths. Noncommunicable...
Darbepoetin alfa (Cresp) Boosts Hemoglobin Levels in Chemotherapy-Induced Anemia (CIA): Results of Indian Analysis Deeksha Bhandari4 April 2025 11:58 AM ISTDarbepoetin alfa effectively increases hemoglobin levels and reduces blood transfusion needs among chemotherapy-induced anemia (CIA) patients,...
Managing Urinary Tract Infections - The Role of Holistic Medicine Dr. Garima Soni2 April 2025 12:30 PM ISTUrinary Tract Infections (UTIs) are a significant burden on global health, affecting millions of people each year and occurring in various forms...
Neonatal and Infant Skincare: Indian Healthcare Professionals Perspectives on Parent's Awareness and Product Prescription Patterns Dr. Kamal Kant Kohli28 March 2025 12:21 PM ISTProper product prescription and utilization by Healthcare professionals (HCP's) and parents is key to ensuring healthy skin development in newborns,...
Adherence Matters: The Critical Role Of Healthcare Professionals In Improving Patient Outcomes Dr. Kamal Kant Kohli27 March 2025 8:45 AM ISTUnderstanding the Science Behind AdherenceDespite remarkable advancements in the treatment of chronic diseases, complications and mortality rates...
Association of Physicians of India Consensus Recommendations for Vonoprazan in Management of Acid Peptic Disorders Dr. Kamal Kant Kohli26 March 2025 11:36 AM ISTThe Association of Physicians of India (API) has recently issued a consensus statement, highlighting vonoprazan as an effective option for managing...
WHO Silent on Strategy After US Funding Withdrawal - Dr S K Gupta S.K. Gupta18 March 2025 1:54 PM IST At the WHO Global Health Issues Press Conference on March 17, 2025, the World Health Organization (WHO) remained silent on its long-term ...
